Advertisement

Topics

Amryt Pharma creating the building blocks for commercial success

03:48 EDT 17 Apr 2019 | Proactive Investors

Driving growth was Lojuxta, used to treat a rare and life-threatening disorder that causes abnormally high levels of bad cholesterol. Its sales grew to €13.6mln, up 14.2% year-on-year

Original Article: Amryt Pharma creating the building blocks for commercial success

NEXT ARTICLE

More From BioPortfolio on "Amryt Pharma creating the building blocks for commercial success"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...